Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 22, 2015 at 9:07 AM EDT

Will One of the Health Insurance Mergers Get a Cold Shoulder?

Merger talks within the health insurance sector are reaching a critical point, and it appears that there will be some…

Jon C. Ogg | Jun 19, 2015 at 2:05 PM EDT

CBO Cost Assumptions of Repealing Affordable Care Are Very Back-End Loaded

What is the public supposed to think when the Affordable Care Act is still under attack and the CBO says…

Chris Lange | Jun 19, 2015 at 9:45 AM EDT

Healthways Trips Over Revised Guidance

Healthways announced that it will revise its guidance for 2015 due to lower than expected revenue from a single health…

Jon C. Ogg | Jun 18, 2015 at 1:40 PM EDT

3 Drivers Supporting BioMarin

BioMarin Pharmaceutical has three key drivers helping out its shares on Thursday: drug news, analyst support, record high Nasdaq.

Chris Lange | Jun 18, 2015 at 11:45 AM EDT

Key Analyst Sees Solid Upside in Eli Lilly

Eli Lilly has made a big splash in the market over the past year. A key analyst sees this trend…

Jon C. Ogg | Jun 18, 2015 at 11:10 AM EDT

Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains

A fresh report implies that Synergy shares, even after the monumental gain on Wednesday, could actually more than double.

Chris Lange | Jun 17, 2015 at 10:45 AM EDT

What Allergan Is Looking to Add With Kythera

Allergan and Kythera Biopharmaceuticals announced that they have entered into a definitive agreement in which the former will acquire he…

Chris Lange | Jun 17, 2015 at 10:20 AM EDT

How Synergy Is Bringing the Ultimate Relief to Shareholders

If a drug is approved or passes a clinical trial, there can be a huge upside for the stock, like…

Chris Lange | Jun 17, 2015 at 10:00 AM EDT

How Much Can Celgene’s Buyback Impact Its Growth?

Celgene announced that its board authorized the repurchase of up to an additional $4.0 billion of its common stock.

Lee Jackson | Jun 17, 2015 at 9:35 AM EDT

4 Health Care Stocks That Are Very Likely Buyout Targets

In a new report, Stifel opines that the consolidation in the managed care organizations is not a matter of if,…

Jon C. Ogg | Jun 16, 2015 at 3:49 PM EDT

Could the Health Insurance Mergers Leave an Odd Man Out?

24/7 Wall St. cannot help but wonder if it is possible that one of these top health insurance companies could…

Chris Lange | Jun 12, 2015 at 11:25 AM EDT

Is Sunesis Coming Back From the Dead?

ThinkstockSunesis Pharmaceuticals Inc. (NASDAQ: SNSS) was making moves as the week drew to a close. This company was part of…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Jun 10, 2015 at 7:55 AM EDT

Short Sellers Lose Some Conviction Against Big Biotech

The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech…

Jon C. Ogg | Jun 9, 2015 at 2:20 PM EDT

Why MannKind Could Be an Endless Tug-of-War Stock

MannKind remains one of the biggest battleground stocks out there in the realm of biotech and emerging pharmacueticals.

1 … 259 260 261 262 263 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Will One of the Health Insurance Mergers Get a Cold Shoulder?

CBO Cost Assumptions of Repealing Affordable Care Are Very Back-End Loaded

Healthways Trips Over Revised Guidance

3 Drivers Supporting BioMarin

Key Analyst Sees Solid Upside in Eli Lilly

Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains

What Allergan Is Looking to Add With Kythera

How Synergy Is Bringing the Ultimate Relief to Shareholders

How Much Can Celgene’s Buyback Impact Its Growth?

4 Health Care Stocks That Are Very Likely Buyout Targets

Could the Health Insurance Mergers Leave an Odd Man Out?

Is Sunesis Coming Back From the Dead?

Short Sellers Back Off Big Pharma

Short Sellers Lose Some Conviction Against Big Biotech

Why MannKind Could Be an Endless Tug-of-War Stock

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Will One of the Health Insurance Mergers Get a Cold Shoulder?

CBO Cost Assumptions of Repealing Affordable Care Are Very Back-End Loaded

Healthways Trips Over Revised Guidance

3 Drivers Supporting BioMarin

Key Analyst Sees Solid Upside in Eli Lilly

Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains

What Allergan Is Looking to Add With Kythera

How Synergy Is Bringing the Ultimate Relief to Shareholders

How Much Can Celgene’s Buyback Impact Its Growth?

4 Health Care Stocks That Are Very Likely Buyout Targets

Could the Health Insurance Mergers Leave an Odd Man Out?

Is Sunesis Coming Back From the Dead?

Short Sellers Back Off Big Pharma

Short Sellers Lose Some Conviction Against Big Biotech

Why MannKind Could Be an Endless Tug-of-War Stock

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how